Clincosm LogoSign in Get a demo

Hematologic Diseases

Showing NaN - NaN of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)

Recruiting
  • CML
  • +3 more
  • Asciminib add-on
  • +3 more
  • Augusta, Georgia
  • +46 more
Jan 23, 2023

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

Active, not recruiting
  • Leukemia
  • +7 more
  • Boston, Massachusetts
  • +10 more
Jan 19, 2023

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +9 more
Sep 9, 2022

Hematologic Diseases, Leukemia, Lymphoma Trial in Houston (Busulfan, Fludarabine, Cyclophosphamide)

Completed
Has Results
  • Hematologic Diseases
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 28, 2016

Myelodysplastic and Myeloproliferative Disorders, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Houston

Terminated
Has Results
  • Myelodysplastic and Myeloproliferative Disorders
  • +7 more
  • Houston, Texas
  • +1 more
Mar 29, 2016

Version of Common Terminology Criteria Cognitive Debriefing

Completed
  • Advanced Cancers
  • +2 more
  • Interview
  • Boston, Massachusetts
  • +3 more
Jul 10, 2014